GLTO - Galecto, Inc. Common Stock -  [ ]

Ticker Details
Galecto, Inc. Common Stock
IPO Date: October 29, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.73B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.24 | 4.12%
Avg Daily Range (30 D): $0.99 | 3.33%
Avg Daily Range (90 D): $1.54 | 6.11%
Institutional Daily Volume
Avg Daily Volume: .28M
Avg Daily Volume (30 D): .04M
Avg Daily Volume (90 D): .1M
Trade Size
Avg Trade Size (Sh.): 72
Avg Trade Size (Sh.) (30 D): 41
Avg Trade Size (Sh.) (90 D): 68
Institutional Trades
Total Institutional Trades: 65
Avg Institutional Trade: $2.1M
Avg Institutional Trade (30 D): $2.33M
Avg Institutional Trade (90 D): $3M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $2.78M
Avg Closing Trade (30 D): $.56M
Avg Closing Trade (90 D): $4.23M
Avg Closing Volume: 87.3K
 
News
Feb 12, 2026 @ 9:01 PM
Galecto Announces Closing of Public Offering and F...
Source: Globe Newswire
Feb 11, 2026 @ 3:42 AM
Galecto Announces Pricing of $275 Million Underwri...
Source: Na
Dec 16, 2025 @ 10:00 PM
Galecto, Inc. Announces Inducement Grant Under Nas...
Source: Galecto, Inc.
Nov 10, 2025 @ 4:47 PM
Galecto Stock Soars: Strengthens Blood Cancer Pipe...
Source: Vandana Singh
Nov 10, 2025 @ 12:00 PM
Galecto Announces Acquisition of Damora Therapeuti...
Source: Galecto, Inc.
Financials
  TTM Q4 2025 FY 2025
Basic EPS $3.98 $10.86 $3.98
Diluted EPS $3.98 $10.86 $3.98
Revenue $1.17M $1M $1.17M
Gross Profit
Net Income / Loss $-209.84M $-200.74M $-209.84M
Operating Income / Loss $-210.87M $-201.7M $-210.87M
Cost of Revenue
Net Cash Flow $243.45M $250.02M $243.45M
PE Ratio    
Splits
Aug 30, 2024 1:25